tokens: Previously , we found TP53 mutations affecting the L2 / L3 DNA binding domain to be associated with lack of responsiveness to doxorubicin monotherapy [ 13 ] as well as mitomycin and 5 - fluoro - uracil in concert [ 14 ] .